Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2

Romain A. Colas, Anthony W. Ashton, Shankar Mukherjee, Jesmond Dalli, Oscar B. Akide-Ndunge, Huan Huang, Mahalia S. Desruisseaux, Fangxia Guan, Linda A. Jelicks, Fabiane Matos dos Santos, Jyothi Nagajyothi, Michael A. Zingman, Jinet Reyes, Louis M. Weiss, Charles N. Serhan, Herbert B. Tanowitz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Trypanosoma cruzi is a protozoan parasite that causes Chagas disease (CD). CD is a persistent, lifelong infection affecting many organs, most notably the heart, where it may result in acute myocarditis and chronic cardiomyopathy. The pathological features include myocardial inflammation and fibrosis. In the Brazil strain-infected CD-1 mouse, which recapitulates many of the features of human infection, we found increased plasma levels of resolvin D1 (RvD1), a specialized proresolving mediator of inflammation, during both the acute and chronic phases of infection (>100 days postinfection) as determined by enzyme-linked immunosorbent assay (ELISA). Additionally, ELISA on lysates of trypomastigotes of both strains Tulahuen and Brazil revealed elevated levels of RvD1 compared with lysates of cultured epimastigotes of T. cruzi, tachyzoites of Toxoplasma gondii, trypomastigotes of Trypanosoma brucei, cultured L6E9 myoblasts, and culture medium containing no cells. Lysates of T. cruzi-infected myoblasts also displayed increased levels of RvD1. Lipid mediator metabolomics confirmed that the trypomastigotes of T. cruzi produced RvD1, RvD5, and RvE2, which have been demonstrated to modulate the host response to bacterial infections. Plasma RvD1 levels may be both host and parasite derived. Since T. cruzi synthesizes specialized proresolving mediators of inflammation, as well as proinflammatory eicosanoids, such as thromboxane A2, one may speculate that by using these lipid mediators to modulate its microenvironment, the parasite is able to survive.

Original languageEnglish (US)
Article numbere00688-17
JournalInfection and Immunity
Volume86
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Trypanosoma cruzi
Chagas Disease
Inflammation Mediators
Parasites
Myoblasts
Brazil
Infection
Enzyme-Linked Immunosorbent Assay
Lipids
Trypanosoma brucei brucei
Thromboxane A2
Metabolomics
Eicosanoids
Myocarditis
Toxoplasma
Cardiomyopathies
Bacterial Infections
Culture Media
Fibrosis
resolvin D5

Keywords

  • Chagas disease
  • Eicosanoids
  • Host-parasite relationship
  • Immune modulation
  • Inflammation
  • Resolvin
  • Resolvin D1
  • Resolvin D5
  • Resolvin E2
  • Resolvins
  • Trypanosoma cruzi

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases

Cite this

Colas, R. A., Ashton, A. W., Mukherjee, S., Dalli, J., Akide-Ndunge, O. B., Huang, H., ... Tanowitz, H. B. (2018). Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2. Infection and Immunity, 86(4), [e00688-17]. https://doi.org/10.1128/IAI.00688-17

Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2. / Colas, Romain A.; Ashton, Anthony W.; Mukherjee, Shankar; Dalli, Jesmond; Akide-Ndunge, Oscar B.; Huang, Huan; Desruisseaux, Mahalia S.; Guan, Fangxia; Jelicks, Linda A.; dos Santos, Fabiane Matos; Nagajyothi, Jyothi; Zingman, Michael A.; Reyes, Jinet; Weiss, Louis M.; Serhan, Charles N.; Tanowitz, Herbert B.

In: Infection and Immunity, Vol. 86, No. 4, e00688-17, 01.04.2018.

Research output: Contribution to journalArticle

Colas, RA, Ashton, AW, Mukherjee, S, Dalli, J, Akide-Ndunge, OB, Huang, H, Desruisseaux, MS, Guan, F, Jelicks, LA, dos Santos, FM, Nagajyothi, J, Zingman, MA, Reyes, J, Weiss, LM, Serhan, CN & Tanowitz, HB 2018, 'Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2', Infection and Immunity, vol. 86, no. 4, e00688-17. https://doi.org/10.1128/IAI.00688-17
Colas, Romain A. ; Ashton, Anthony W. ; Mukherjee, Shankar ; Dalli, Jesmond ; Akide-Ndunge, Oscar B. ; Huang, Huan ; Desruisseaux, Mahalia S. ; Guan, Fangxia ; Jelicks, Linda A. ; dos Santos, Fabiane Matos ; Nagajyothi, Jyothi ; Zingman, Michael A. ; Reyes, Jinet ; Weiss, Louis M. ; Serhan, Charles N. ; Tanowitz, Herbert B. / Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2. In: Infection and Immunity. 2018 ; Vol. 86, No. 4.
@article{c0d5ebf95f0e49f2942e229592f8c42c,
title = "Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2",
abstract = "Trypanosoma cruzi is a protozoan parasite that causes Chagas disease (CD). CD is a persistent, lifelong infection affecting many organs, most notably the heart, where it may result in acute myocarditis and chronic cardiomyopathy. The pathological features include myocardial inflammation and fibrosis. In the Brazil strain-infected CD-1 mouse, which recapitulates many of the features of human infection, we found increased plasma levels of resolvin D1 (RvD1), a specialized proresolving mediator of inflammation, during both the acute and chronic phases of infection (>100 days postinfection) as determined by enzyme-linked immunosorbent assay (ELISA). Additionally, ELISA on lysates of trypomastigotes of both strains Tulahuen and Brazil revealed elevated levels of RvD1 compared with lysates of cultured epimastigotes of T. cruzi, tachyzoites of Toxoplasma gondii, trypomastigotes of Trypanosoma brucei, cultured L6E9 myoblasts, and culture medium containing no cells. Lysates of T. cruzi-infected myoblasts also displayed increased levels of RvD1. Lipid mediator metabolomics confirmed that the trypomastigotes of T. cruzi produced RvD1, RvD5, and RvE2, which have been demonstrated to modulate the host response to bacterial infections. Plasma RvD1 levels may be both host and parasite derived. Since T. cruzi synthesizes specialized proresolving mediators of inflammation, as well as proinflammatory eicosanoids, such as thromboxane A2, one may speculate that by using these lipid mediators to modulate its microenvironment, the parasite is able to survive.",
keywords = "Chagas disease, Eicosanoids, Host-parasite relationship, Immune modulation, Inflammation, Resolvin, Resolvin D1, Resolvin D5, Resolvin E2, Resolvins, Trypanosoma cruzi",
author = "Colas, {Romain A.} and Ashton, {Anthony W.} and Shankar Mukherjee and Jesmond Dalli and Akide-Ndunge, {Oscar B.} and Huan Huang and Desruisseaux, {Mahalia S.} and Fangxia Guan and Jelicks, {Linda A.} and {dos Santos}, {Fabiane Matos} and Jyothi Nagajyothi and Zingman, {Michael A.} and Jinet Reyes and Weiss, {Louis M.} and Serhan, {Charles N.} and Tanowitz, {Herbert B.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1128/IAI.00688-17",
language = "English (US)",
volume = "86",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2

AU - Colas, Romain A.

AU - Ashton, Anthony W.

AU - Mukherjee, Shankar

AU - Dalli, Jesmond

AU - Akide-Ndunge, Oscar B.

AU - Huang, Huan

AU - Desruisseaux, Mahalia S.

AU - Guan, Fangxia

AU - Jelicks, Linda A.

AU - dos Santos, Fabiane Matos

AU - Nagajyothi, Jyothi

AU - Zingman, Michael A.

AU - Reyes, Jinet

AU - Weiss, Louis M.

AU - Serhan, Charles N.

AU - Tanowitz, Herbert B.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Trypanosoma cruzi is a protozoan parasite that causes Chagas disease (CD). CD is a persistent, lifelong infection affecting many organs, most notably the heart, where it may result in acute myocarditis and chronic cardiomyopathy. The pathological features include myocardial inflammation and fibrosis. In the Brazil strain-infected CD-1 mouse, which recapitulates many of the features of human infection, we found increased plasma levels of resolvin D1 (RvD1), a specialized proresolving mediator of inflammation, during both the acute and chronic phases of infection (>100 days postinfection) as determined by enzyme-linked immunosorbent assay (ELISA). Additionally, ELISA on lysates of trypomastigotes of both strains Tulahuen and Brazil revealed elevated levels of RvD1 compared with lysates of cultured epimastigotes of T. cruzi, tachyzoites of Toxoplasma gondii, trypomastigotes of Trypanosoma brucei, cultured L6E9 myoblasts, and culture medium containing no cells. Lysates of T. cruzi-infected myoblasts also displayed increased levels of RvD1. Lipid mediator metabolomics confirmed that the trypomastigotes of T. cruzi produced RvD1, RvD5, and RvE2, which have been demonstrated to modulate the host response to bacterial infections. Plasma RvD1 levels may be both host and parasite derived. Since T. cruzi synthesizes specialized proresolving mediators of inflammation, as well as proinflammatory eicosanoids, such as thromboxane A2, one may speculate that by using these lipid mediators to modulate its microenvironment, the parasite is able to survive.

AB - Trypanosoma cruzi is a protozoan parasite that causes Chagas disease (CD). CD is a persistent, lifelong infection affecting many organs, most notably the heart, where it may result in acute myocarditis and chronic cardiomyopathy. The pathological features include myocardial inflammation and fibrosis. In the Brazil strain-infected CD-1 mouse, which recapitulates many of the features of human infection, we found increased plasma levels of resolvin D1 (RvD1), a specialized proresolving mediator of inflammation, during both the acute and chronic phases of infection (>100 days postinfection) as determined by enzyme-linked immunosorbent assay (ELISA). Additionally, ELISA on lysates of trypomastigotes of both strains Tulahuen and Brazil revealed elevated levels of RvD1 compared with lysates of cultured epimastigotes of T. cruzi, tachyzoites of Toxoplasma gondii, trypomastigotes of Trypanosoma brucei, cultured L6E9 myoblasts, and culture medium containing no cells. Lysates of T. cruzi-infected myoblasts also displayed increased levels of RvD1. Lipid mediator metabolomics confirmed that the trypomastigotes of T. cruzi produced RvD1, RvD5, and RvE2, which have been demonstrated to modulate the host response to bacterial infections. Plasma RvD1 levels may be both host and parasite derived. Since T. cruzi synthesizes specialized proresolving mediators of inflammation, as well as proinflammatory eicosanoids, such as thromboxane A2, one may speculate that by using these lipid mediators to modulate its microenvironment, the parasite is able to survive.

KW - Chagas disease

KW - Eicosanoids

KW - Host-parasite relationship

KW - Immune modulation

KW - Inflammation

KW - Resolvin

KW - Resolvin D1

KW - Resolvin D5

KW - Resolvin E2

KW - Resolvins

KW - Trypanosoma cruzi

UR - http://www.scopus.com/inward/record.url?scp=85044323396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044323396&partnerID=8YFLogxK

U2 - 10.1128/IAI.00688-17

DO - 10.1128/IAI.00688-17

M3 - Article

VL - 86

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 4

M1 - e00688-17

ER -